US57060D1081 - Common Stock

**MKTX** gets a fundamental rating of **6** out of 10. The analysis compared the fundamentals against 220 industry peers in the **Capital Markets** industry. **MKTX** gets an excellent profitability rating and is at the same time showing great financial health properties. **MKTX** is valied quite expensively at the moment, while it does show a decent growth rate. This makes **MKTX** very considerable for quality investing!

In the past 5 years **MKTX** has always been profitable.

The **Return On Assets** of **MKTX** (**13.89%**) is better than **95.35%** of its industry peers.

The **Return On Equity** of **MKTX** (**19.72%**) is better than **88.37%** of its industry peers.

Looking at the **Return On Invested Capital**, with a value of **17.92%**, **MKTX** belongs to the top of the industry, outperforming **93.02%** of the companies in the same industry.

The **Average Return On Invested Capital** over the past 3 years for **MKTX** is significantly above the industry average of **7.91%**.

Industry Rank | Sector Rank | ||
---|---|---|---|

ROA | 13.89% | ||

ROE | 19.72% | ||

ROIC | 17.92% |

ROA(3y)15.07%

ROA(5y)17.83%

ROE(3y)22.62%

ROE(5y)25.16%

ROIC(3y)21.88%

ROIC(5y)23.96%

The **Profit Margin** of **MKTX** (**33.71%**) is better than **68.84%** of its industry peers.

In the last couple of years the **Operating Margin** of **MKTX** has declined.

Industry Rank | Sector Rank | ||
---|---|---|---|

OM | 40.87% | ||

PM (TTM) | 33.71% | ||

GM | 89.6% |

OM growth 3Y-8.36%

OM growth 5Y-3.03%

PM growth 3Y-7.58%

PM growth 5Y-2.88%

GM growth 3Y-2.02%

GM growth 5Y-1.1%

The number of shares outstanding for **MKTX** has been increased compared to 5 years ago.

An Altman-Z score of **11.85** indicates that **MKTX** is not in any danger for bankruptcy at the moment.

There is no outstanding debt for **MKTX**. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.

Industry Rank | Sector Rank | ||
---|---|---|---|

Debt/Equity | 0 | ||

Debt/FCF | 0 | ||

Altman-Z | 11.85 |

ROIC/WACCN/A

WACCN/A

A Current Ratio of **2.28** indicates that **MKTX** has no problem at all paying its short term obligations.

A Quick Ratio of **2.28** indicates that **MKTX** has no problem at all paying its short term obligations.

Looking at the **Quick ratio**, with a value of **2.28**, **MKTX** is in the better half of the industry, outperforming **72.56%** of the companies in the same industry.

Industry Rank | Sector Rank | ||
---|---|---|---|

Current Ratio | 2.28 | ||

Quick Ratio | 2.28 |

The **Earnings Per Share** has been growing by **9.21%** on average over the past years. This is quite good.

Looking at the last year, **MKTX** shows a small growth in **Revenue**. The Revenue has grown by **6.07%** in the last year.

Measured over the past years, **MKTX** shows a quite strong growth in **Revenue**. The Revenue has been growing by **11.55%** on average per year.

EPS 1Y (TTM)7.15%

EPS 3Y-3.29%

EPS 5Y9.21%

EPS Q2Q%8.18%

Revenue 1Y (TTM)6.07%

Revenue growth 3Y2.97%

Revenue growth 5Y11.55%

Sales Q2Q%9.91%

Based on estimates for the next years, **MKTX** will show a quite strong growth in **Earnings Per Share**. The EPS will grow by **10.26%** on average per year.

The **Revenue** is expected to grow by **8.91%** on average over the next years. This is quite good.

EPS Next Y-0.49%

EPS Next 2Y6.66%

EPS Next 3Y9.44%

EPS Next 5Y10.26%

Revenue Next Year7.91%

Revenue Next 2Y9.44%

Revenue Next 3Y9.94%

Revenue Next 5Y8.91%

The EPS growth rate is stable: in the next years the growth will be about the same than in the last years.

The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.

With a **Price/Earnings** ratio of **32.83**, **MKTX** can be considered very expensive at the moment.

Based on the **Price/Earnings** ratio, **MKTX** is valued a bit more expensive than 76.28% of the companies in the same industry.

When comparing the **Price/Earnings** ratio of **MKTX** to the average of the S&P500 Index (**28.79**), we can say **MKTX** is valued inline with the index average.

A **Price/Forward Earnings** ratio of **29.22** indicates a quite expensive valuation of **MKTX**.

When comparing the **Price/Forward Earnings** ratio of **MKTX** to the average of the S&P500 Index (**20.38**), we can say **MKTX** is valued slightly more expensively.

Industry Rank | Sector Rank | ||
---|---|---|---|

PE | 32.83 | ||

Fwd PE | 29.22 |

Based on the **Enterprise Value to EBITDA** ratio, **MKTX** is valued a bit cheaper than 66.98% of the companies in the same industry.

Compared to the rest of the industry, the **Price/Free Cash Flow** ratio of **MKTX** is on the same level as its industry peers.

Industry Rank | Sector Rank | ||
---|---|---|---|

P/FCF | 32.9 | ||

EV/EBITDA | 21.35 |

PEG (NY)N/A

PEG (5Y)3.56

EPS Next 2Y6.66%

EPS Next 3Y9.44%

With a **Yearly Dividend Yield** of **1.28%**, **MKTX** has a reasonable but not impressive dividend return.

Compared to an average industry **Dividend Yield** of **7.67**, **MKTX** is paying slightly less dividend.

Compared to an average S&P500 **Dividend Yield** of **2.32**, **MKTX**'s dividend is way lower than the S&P500 average.

Industry Rank | Sector Rank | ||
---|---|---|---|

Dividend Yield | 1.28% |

The dividend of **MKTX** is nicely growing with an annual growth rate of **11.85%**!

Dividend Growth(5Y)11.85%

Div Incr Years10

Div Non Decr Years10

The dividend of **MKTX** is growing, but the earnings are growing slower. This means the dividend growth is not sustainable.

DP42.64%

EPS Next 2Y6.66%

EPS Next 3Y9.44%

**MARKETAXESS HOLDINGS INC**

NASDAQ:MKTX (8/9/2024, 7:01:06 PM)

After market: 236.06 0 (0%)**236.06**

**+4.17 (+1.8%) **

Chartmill FA Rating

GICS SectorFinancials

GICS IndustryGroupFinancial Services

GICS IndustryCapital Markets

Earnings (Last)

Earnings (Next)

Inst Owners

Inst Owner Change

Ins Owners

Ins Owner Change

Market Cap8.95B

Analysts

Price Target

Dividend

Industry Rank | Sector Rank | ||
---|---|---|---|

Dividend Yield | 1.28% |

Dividend Growth(5Y)

DP

Div Incr Years

Div Non Decr Years

Ex-Date

Surprises & Revisions

EPS beat(2)

Avg EPS beat(2)

Min EPS beat(2)

Max EPS beat(2)

EPS beat(4)

Avg EPS beat(4)

Min EPS beat(4)

Max EPS beat(4)

EPS beat(8)

Avg EPS beat(8)

EPS beat(12)

Avg EPS beat(12)

EPS beat(16)

Avg EPS beat(16)

Revenue beat(2)

Avg Revenue beat(2)

Min Revenue beat(2)

Max Revenue beat(2)

Revenue beat(4)

Avg Revenue beat(4)

Min Revenue beat(4)

Max Revenue beat(4)

Revenue beat(8)

Avg Revenue beat(8)

Revenue beat(12)

Avg Revenue beat(12)

Revenue beat(16)

Avg Revenue beat(16)

PT rev (1m)

PT rev (3m)

EPS NQ rev (1m)

EPS NQ rev (3m)

EPS NY rev (1m)

EPS NY rev (3m)

Revenue NQ rev (1m)

Revenue NQ rev (3m)

Revenue NY rev (1m)

Revenue NY rev (3m)

Valuation

Industry Rank | Sector Rank | ||
---|---|---|---|

PE | 32.83 | ||

Fwd PE | 29.22 | ||

P/S | |||

P/FCF | |||

P/OCF | |||

P/B | |||

P/tB | |||

EV/EBITDA |

EPS(TTM)

EY

EPS(NY)

Fwd EY

FCF(TTM)

FCFY

OCF(TTM)

OCFY

SpS

BVpS

TBVpS

PEG (NY)N/A

PEG (5Y)3.56

Profitability

Industry Rank | Sector Rank | ||
---|---|---|---|

ROA | 13.89% | ||

ROE | 19.72% | ||

ROCE | |||

ROIC | |||

ROICexc | |||

ROICexgc | |||

OM | 40.87% | ||

PM (TTM) | 33.71% | ||

GM | 89.6% | ||

FCFM |

ROA(3y)

ROA(5y)

ROE(3y)

ROE(5y)

ROIC(3y)

ROIC(5y)

ROICexc(3y)

ROICexc(5y)

ROICexgc(3y)

ROICexgc(5y)

ROCE(3y)

ROCE(5y)

ROICexcg growth 3Y

ROICexcg growth 5Y

ROICexc growth 3Y

ROICexc growth 5Y

OM growth 3Y

OM growth 5Y

PM growth 3Y

PM growth 5Y

GM growth 3Y

GM growth 5Y

F-Score

Asset Turnover0.41

Health

Industry Rank | Sector Rank | ||
---|---|---|---|

Debt/Equity | 0 | ||

Debt/FCF | |||

Debt/EBITDA | |||

Cap/Depr | |||

Cap/Sales | |||

Interest Coverage | |||

Cash Conversion | |||

Profit Quality | |||

Current Ratio | 2.28 | ||

Quick Ratio | 2.28 | ||

Altman-Z |

F-Score

WACC

ROIC/WACC

Cap/Depr(3y)

Cap/Depr(5y)

Cap/Sales(3y)

Cap/Sales(5y)

Profit Quality(3y)

Profit Quality(5y)

High Growth Momentum

Growth

EPS 1Y (TTM)7.15%

EPS 3Y-3.29%

EPS 5Y

EPS Q2Q%

EPS Next Y-0.49%

EPS Next 2Y

EPS Next 3Y

EPS Next 5Y

Revenue 1Y (TTM)6.07%

Revenue growth 3Y2.97%

Revenue growth 5Y

Sales Q2Q%

Revenue Next Year

Revenue Next 2Y

Revenue Next 3Y

Revenue Next 5Y

EBIT growth 1Y

EBIT growth 3Y

EBIT growth 5Y

EBIT Next Year

EBIT Next 3Y

EBIT Next 5Y

FCF growth 1Y

FCF growth 3Y

FCF growth 5Y

OCF growth 1Y

OCF growth 3Y

OCF growth 5Y